Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 6 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 11535651

    Hepatitis B nanoparticle-based vaccine for influenza virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  2. US 11534488

    Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability

    VACCINEX, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  3. US 11530432

    Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates

    Northwestern University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  4. US 11512117

    Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  5. US 11491111

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  6. US 11484581

    Method to create personalized canine cancer vaccines

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted

  7. US 11478517

    Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

    The Board of Regents of the University of Texas System · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  8. US 11478541

    Method for inactivating Zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  9. US 11464815

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  10. US 11427634

    Human anti-semaphorin 4D antibody

    VACCINEX, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  11. US 11426461

    Methods for preventing dengue and hepatitis A

    Takeda Vaccines, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  12. US 11421021

    Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted

  13. US 11400150

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  14. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    PDS Biotechnology Corporation · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  15. US 11395850

    RSV vaccines and methods of production and use thereof

    The Board of Regents for Oklahoma State University · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted

  16. US 11376324

    Sting activating nanovaccine for immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  17. US 11369675

    Broadly protective inactivated influenza virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  18. US 11364293

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  19. US 11357842

    PD-L1 targeting DNA vaccine for cancer immunotherapy

    Vaximm AG · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  20. US 11338029

    Cancer vaccines targeting PRAME and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  21. US 11338028

    Cancer vaccines targeting LEMD1 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  22. US 11331383

    Attenuated african swine fever virus vaccine

    The Pirbright Institute · Granted May 17, 2022 · Expires May 12, 2042

    granted

  23. US 11332722

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  24. AU 2020370603

    Chikungunya virus-like particle vaccine and methods of using the same

    BAVARIAN NORDIC AS [DK] · Granted May 12, 2022 · Expires May 7, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.